Login

Jui-Che Hsu

ORCID: 0000-0003-2611-165X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5087689649
Research Areas
  • Hepatitis C virus research
  • HIV, Drug Use, Sexual Risk
  • Hepatitis B Virus Studies

An-Nan Hospital
 2022

China Medical University
 2022

 Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users
OPENALEX - Publications 
Jui-Ting Hsu Ping‐I Hsu Chang‐Bih Shie Seng‐Kee Chuah I‐Ting Wu and 7 more Wenwei Huang Sheng‐Yeh Tang Kun‐Feng Tsai Li‐Fu Kuo Supratip Ghose Jui-Che Hsu Chih‐An Shih

Background and Objectives: Hepatitis C virus (HCV) is a major cause of liver disease worldwide. People who inject drugs (PWIDs) constitute the majority patients with HCV infection in United States Central Asia. There are several obstacles to treating PWIDs because often accompanied by concurrent infection, low compliance, substance abuse, risky behavior. The aim study compare efficacies direct-acting antiviral (DAA) therapy for those without opioid injection. Materials Methods: In this...

10.3390/medicina58030436 article EN cc-by Medicina 2022-03-17
Coming Soon ...